A Phase 2b Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat.
Condition: Subcutaneous Fat Interventions: Drug: CBL-514 injection; Drug: CBL-A1 Injection; Drug: CBL-A2 Injection; Drug: 0.9% Sodium Chloride Sponsor: Caliway Biopharmaceuticals Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
A Study to Find Out if ASP5354 Can Clearly Help Show the Ureter During Surgery in People With or Without Kidney Disease
Conditions: Intraoperative Ureter Visualization; Abdominolpelvic Surgery Intervention: Drug: pudexacianinium chloride Sponsor: Astellas Pharma Global Development, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials
